Diagnosis and management of adrenal insufficiency (Q38237464)

31 August 2017

Diagnosis and management of adrenal insufficiency (English)

1 reference

31 August 2017

Irina Bancos

1

0 references

Jeremy W Tomlinson

object named as

Jeremy Tomlinson

series ordinal

3

0 references

Stefanie Hahner

object named as

Stefanie Hahner

series ordinal

2

0 references

Wiebke Arlt

object named as

Wiebke Arlt

series ordinal

4

0 references

language of work or name

1 reference

3 August 2014

1 reference

The Lancet: Diabetes & Endocrinology

31 August 2017

1 reference

31 August 2017

3

1 reference

31 August 2017

216-226

1 reference

31 August 2017

3

1 reference

Eighty-six cases of Addison's disease

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

High prevalence and increasing incidence of Addison's disease in western Norway

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Autoimmune Addison disease: pathophysiology and genetic complexity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Modified-release hydrocortisone to provide circadian cortisol profiles

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

ORIGINAL ARTICLE: Autoimmunity predominates in a large South African cohort with addison’s disease of mainly European descent despite long-standing disease and is associated with HLA DQB*0201

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

The Polyglandular Failure Syndrome: Disease Inheritance, HLA Type, and Immune Function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Diagnosis of adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Rapid assessment of corticotropin reserve after pituitary surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Factors determining inadequate hypoglycaemia during insulin tolerance testing (ITT) after pituitary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Recovery of pituitary function in the late-postoperative phase after pituitary surgery: results of dynamic testing in patients with pituitary disease by insulin tolerance test 3 and 12 months after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

21-Hydroxylase, a major autoantigen in idiopathic Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Metastases in carcinoma; analysis of 1000 autopsied cases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Assessment of endogenous, oral and inhaled steroid cross-reactivity in the Roche cortisol immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Adrenal function improves in asthmatic children on inhaled steroids: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

High-calorie glucose-rich food attenuates neuroglycopenic symptoms in patients with Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

DHEA replacement in women with adrenal insufficiency--pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Androgen replacement in adolescents and young women with hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

The first simultaneous kidney-adrenal gland-pancreas transplantation: outcome at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Adrenal crisis in treated Addison's disease: a predictable but under-managed event

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

How to avoid precipitating an acute adrenal crisis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Self-management of adrenal insufficiency by rectal hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Sexuality and fertility in women with Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Addison's disease in women is a risk factor for an adverse pregnancy outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Continuous subcutaneous hydrocortisone infusion in Addison's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Premature mortality in patients with Addison's disease: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Risk of hip fracture in Addison's disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970142-1

7 January 2021

10.1016/S2213-8587(14)70142-1

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

25098712